Applications of 2-Bromo-2-(2'-Chlorophenyl) Acetic Acid in Industrial Manufacturing

2-Bromo-2-(2'-Chlorophenyl) Acetic Acid serves as a critical synthetic intermediate across several fine chemical sectors. As the original manufacturer, we ensure strict quality control and provide comprehensive technical support for each specific downstream use. Below, we detail real industrial application scenarios with practical integration notes based on established usage in industry.

1. Pharmaceutical Intermediates for Non-Steroidal Anti-Inflammatory Drug (NSAID) Synthesis

Major API producers use this compound in the synthesis of select chlorophenylacetic acid-based NSAIDs. Its halogenated structure provides essential reactivity for core intermediate formation. The material participates in key condensation and cyclization steps, supporting batch or continuous manufacturing regimes. Our QC parameters closely align with pharmacopeial standards to support regulatory submissions for human medicines.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• US Pharmacopeia (USP) and European Pharmacopoeia (Ph. Eur.) requirements for API intermediates
• 21 CFR Part 211 (US cGMP regulations)
• REACH registration for substance importation in the EU

Typical usage ratio

• Standard input: 1.0 – 1.2 molar equivalents per corresponding amine or coupling partner in the NSAID intermediate synthesis.
• Variations based on pathway yield or specific condensation route, refined via in-process monitoring.

Downstream process integration

• Introduced at the chlorophenylacetylation stage in the multi-step synthesis.
• Batch or semi-continuous feeding to control exothermic reaction profiles.
• Lifecycle monitored for residual halide content and purity by HPLC.

Final product types

• Chlorinated NSAIDs (e.g., diclofenac, indomethacin analogs)
• Key intermediates for specialty anti-inflammatory APIs

2. Agrochemical Intermediate for Selective Herbicide Manufacture

Crop protection industry formulators rely on this material in the preparation of substituted phenoxyacetic acid herbicides. The compound acts as a halogenated building block for etherification with specialized alkoxy groups. Strict traceability is maintained to document compliance for field application products. We supply technical-grade batches designed for compatibility with plant production QC.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products
• ISO 9001:2015 Quality Management for fine chemicals
• EU Regulation (EC) No 1107/2009 for pesticide registration
• China GB 2763 Maximum Residue Limits requirements (export markets)

Typical usage ratio

• Core intermediate: 0.9 – 1.1 equivalents per target acid moiety in the final herbicide molecule.
• Adjusted depending on downstream etherification yield and scale of process operations.

Downstream process integration

• Mixed with alkoxy reactants during initial synthesis set-up.
• Reacts under controlled temperature and base catalyst conditions to limit side-product formation.
• Completed precursor further processed by chlorination or acidification depending on herbicide structure.

Final product types

• Phenoxyacetic acid-based herbicidal agents
• Pre-mix technical concentrate for agricultural application

3. Fine Chemical Intermediate in Liquid Crystal Display (LCD) Material Synthesis

The electronics sector employs this compound as a halogen donor for the synthesis of specialty aromatic carboxylic acids used in advanced LCD substrates. Its bromo-chloro functionality enables precise introduction of halogen patterns necessary for targeted mesogen design. We supply high-purity lots with trace metallic and halide specification to meet OEM standards, supporting electronics industry certification processes.

Industry compliance standards

• IEC 61249-2-21 for halogen content in electronic materials
• RoHS Directive (EU) 2011/65/EU on hazardous substances in electronics
• JIS C 61133 for material safety in Japanese market
• ISO 14001 Environmental Management certification for supplier qualification

Typical usage ratio

• Synthesis input: 0.8 – 1.3 molar equivalents depending on required halogen load in the liquid crystal precursor.
• Ratios fine-tuned based on desired optical and physical properties of final LCD components.

Downstream process integration

• Used at the halogenation or acylation stage for producing precursor mesogens.
• Integrated via solution-phase reactions; solvent selection by downstream QC.
• Product batch traced for halide content and purity using LC-MS and potentiometric titration.

Final product types

• Liquid crystal intermediates for TFT-LCD panels
• Specialty aromatic acids for advanced display technologies

4. Specialty Intermediate for Veterinary Active Ingredient Synthesis

In the veterinary pharmaceutical sector, chemical manufacturers select this material for assembling halogenated amino acids and non-steroidal actives with applications in animal health products. Precision in stoichiometry and impurity control is paramount to animal drug safety and efficacy. We certify each lot with relevant trace analysis to comply with veterinary drug manufacturing requirements.

Industry compliance standards

• VICH GL10 GMP for veterinary pharmaceutical ingredients
• US FDA 21 CFR Part 226 for medicated feed production
• EU Regulation (EC) No 2019/6 for veterinary medicines
• OECD GLP certification for analytical support

Typical usage ratio

• Input ratios: 1.0 – 1.15 mole per step in the amination, condensation, or cyclization reactions of veterinary actives.
• Adjusted according to feedstock purity and scale of the synthesis line.

Downstream process integration

• Used as an acylating agent at the first or second step in actives’ core synthesis chain.
• Reacted under closely monitored temperature and mixing regimes.
• QC via NMR and melting point determination for batch release.

Final product types

• Halogenated veterinary APIs (anti-inflammatory agents or antiparasitics)
• Intermediate blocks for animal health formulations